Author:
Tizabi Yousef,Getachew Bruk,Copeland Robert L.,Moratalla Rosario,Patricio Felipe,Limón Ilhuicamina Daniel,Del-Bel Elaine,Aschner Michael
Publisher
Springer International Publishing
Reference101 articles.
1. Abioye, A., Ayodele, O., Marinkovic, A., Patidar, R., Akinwekomi, A., & Sanyaolu, A. (2020). Δ9-Tetrahydrocannabivarin (THCV): A commentary on potential therapeutic benefit for the management of obesity and diabetes. Journal of Cannabis Research, 2(1), 6.
2. Alhowail, A. (2021). Molecular insights into the benefits of nicotine on memory and cognition (Review). Molecular Medicine Reports, 23(6), 398.
3. AlShimemeri, S., Fox, S. H., & Visanji, N. P. (2020). Emerging drugs for the treatment of L-DOPA-Induced Dyskinesia: An Update. Expert Opinion on Emerging Drugs, 25(2), 131–144.
4. Anderson, F. L., Coffey, M. M., Berwin, B. L., & Havrda, M. C. (2018). Inflammasomes: An emerging mechanism translating environmental toxicant exposure into Neuroinflammation in Parkinson’s disease. Toxicological Sciences, 166(1), 3–15.
5. Andrade, V., Mateus, M. L., Batoréu, M. C., Aschner, M., & Dos Santos, A. M. (2017). Toxic mechanisms underlying motor activity changes induced by a mixture of lead, arsenic and manganese. EC Pharmacology and Toxicology, 3(2), 31–42.